Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

September 01, 1995; Volume 23,Issue 9
  • You have access
    Relevance of tissue distribution studies and cytopharmacology: utility of radioassay combined with autoradiography.
    W E Stumpf
    Drug Metabolism and Disposition September 1995, 23 (9) 885-886;
  • You have access
    Metabolism of oral 9-cis-retinoic acid in the human. Identification of 9-cis-retinoyl-beta-glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolites.
    J O Sass, E Masgrau, J H Saurat and H Nau
    Drug Metabolism and Disposition September 1995, 23 (9) 887-891;
  • You have access
    Reactivity of gemfibrozil 1-o-beta-acyl glucuronide. Pharmacokinetics of covalently bound gemfibrozil-protein adducts in rats.
    B C Sallustio and D J Foster
    Drug Metabolism and Disposition September 1995, 23 (9) 892-899;
  • You have access
    Stereoselective reversible binding properties of the glucuronide conjugates of fenoprofen enantiomers to human serum albumin.
    A Bischer, M Iwaki, P Zia-Amirhosseini and L Z Benet
    Drug Metabolism and Disposition September 1995, 23 (9) 900-903;
  • You have access
    A comparison of mass balance, pharmacokinetics and disposition of [14C(U)]- and [125I]recombinant human interleukin-2 in cynomolgus monkeys.
    R W Nadeau, H Satoh, S Scheide, R Crowl, R Conroy, W A Garland and D J Liberato
    Drug Metabolism and Disposition September 1995, 23 (9) 904-909;
  • You have access
    Characterization of an O-glucuronide metabolite of the CCK-B antagonist LY288513 and its plasma levels in mouse, rat, and dog.
    J M Woodland and W J Ehlhardt
    Drug Metabolism and Disposition September 1995, 23 (9) 910-915;
  • You have access
    Disposition of the opioid antagonist, LY255582, in rats and dogs.
    S P Swanson, J Catlow, R C Pohland, S H Chay and T Johnson
    Drug Metabolism and Disposition September 1995, 23 (9) 916-921;
  • You have access
    Induction of rodent hepatic drug-metabolizing enzyme activities by the novel anticonvulsant remacemide hydrochloride.
    R J Riley, C Lambert, A E Cooper, H Richmond, M Hall, M C Jordan, C J Logan and B Clark
    Drug Metabolism and Disposition September 1995, 23 (9) 922-928;
  • You have access
    Determination of human hepatic cytochrome P4501A2 activity in vitro use of tacrine as an isoenzyme-specific probe.
    V Spaldin, S Madden, D A Adams, R J Edwards, D S Davies and B K Park
    Drug Metabolism and Disposition September 1995, 23 (9) 929-934;
  • You have access
    Comparison of purified human and rabbit serum paraoxonases.
    C L Kuo and B N La Du
    Drug Metabolism and Disposition September 1995, 23 (9) 935-944;
  • You have access
    Bacterial expression and kinetic characterization of the human monoamine-sulfating form of phenol sulfotransferase.
    T C Ganguly, V Krasnykh and C N Falany
    Drug Metabolism and Disposition September 1995, 23 (9) 945-950;
  • You have access
    Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone.
    A E Mutlib, J T Strupczewski and S M Chesson
    Drug Metabolism and Disposition September 1995, 23 (9) 951-964;
  • You have access
    Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats.
    D M Stresser, D E Williams, D A Griffin and G S Bailey
    Drug Metabolism and Disposition September 1995, 23 (9) 965-975;
  • You have access
    Investigation of the metabolism of ebrotidine in human urine by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
    E Rozman, M T Galceran, L Anglada and C Albet
    Drug Metabolism and Disposition September 1995, 23 (9) 976-981;
  • You have access
    Metabolism of [14C]1,3-dinitrobenzene by rat small intestinal mucosa in vitro.
    P C Adams and D E Rickert
    Drug Metabolism and Disposition September 1995, 23 (9) 982-987;
  • You have access
    Urinary excretion of cicletanine in the rat. Stereochemical aspects.
    R Vistelle, D Lamiable, E Morin, T Trenque and M Kaltenbach
    Drug Metabolism and Disposition September 1995, 23 (9) 988-992;
  • You have access
    Acidic metabolites of tamoxifen. Aspects of formation and fate in the female rat.
    P C Ruenitz and X Bai
    Drug Metabolism and Disposition September 1995, 23 (9) 993-998;
  • You have access
    Inhibition and induction of cytochrome P450 isozymes after repetitive administration of imipramine in rats.
    Y Masubuchi, C Takahashii, N Fujio, T Horie, T Suzuki, S Imaoka, Y Funae and S Narimatsu
    Drug Metabolism and Disposition September 1995, 23 (9) 999-1003;
  • You have access
    Utility of trace trifluoroacetic acid to enhance the quality of proton NMR spectra of xenobiotic metabolites.
    G Y Kuo and D M Dulik
    Drug Metabolism and Disposition September 1995, 23 (9) 1004-1006;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 23, Issue 9
1 Sep 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • Metabolism and Disposition of Volanesorsen across Species
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics